PATENT CLAIM ANALYSIS

Application Number: 16426346
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["424", "195100"]

Abstract:
Various embodiments of the present invention are directed to the field of Oncology, and in particular, embodiments directed to a method of ameliorating, treating, or preventing a malignancy in a human subject wherein the steps of the method assist or boost the immune system in eradicating cancerous cells. Certain embodiments are directed to the field of human longevity and aging in a manner such that cancer is not contracted due to ameliorating, treating, or reducing aging by increasing the healthspan and lifespan of humans. In certain embodiments, administration of beneficial bacteria to an individual's microbiome that have been modified so as to produce effective amounts of desired compositions, compounds, agents, e.g. tomatidine, rapamycin, p53 protein, statins, etc., is employed to treat and prevent cancer and other age-related diseases.

Claim (Index 16):
The method as set forth in  claim 14 , further comprising administering a therapeutically effective amount of a bacterial composition comprising  Streptomyces hygroscopicus  in an amount effective to provide a therapeutically effective amount of rapamycin to the subject.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 100.0
- Lexical Diversity: 1.74118
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15639767', '15437976', '15228454', '16423375', '16160336']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7736366568233634
- 35 USC 102 Novelty (BERT): 0.5878195333597823
- Combined Prediction Score: 0.7550549444770053
- Mean Citation Score: 387.990718
- Max Citation Score: 562.25793
- Similarity Product: 434.920632115134

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test